🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Dr. Mahé Isabelle on the extended anticoagulant treatment with a reduced versus full dose #apixaban in patients with cancer-associated #VTE #ACC25 #JACCJournals #APICAT #CardioOnc #cvCoag

#APICAT trial at #ACC25 #LBCT #cardioonc 🩸apixaban low 2.5 mg vs full dose 5mg in patients with cancer+VTE: primary endpoint recurrent VTE 🩸more than half female! 👏🏽👏🏽 🩸the low dose was significant for noninferiority for efficacy & ⤵️ bleed 🩸no increase in deaths

Low-Dose #Apixaban Prevents Recurrent #VTE in Cancer Beyond 6 Months: API-CAT TCTMD Mamas A. Mamas tctmd.com/news/low-dose-…

Don’t forget that vte prevention and treatment is #cardioonc #apicat shows low dose apixaban non inferior to full dose in reducing recurrent vte in pts with cancer. #jacccardioonc

#ACC25 #CardioOnc session starting now! Practical CO cases to learn from

#whyCMR in #CardioOnc @#ACC25 by Lauren A. Baldassarre, MD, FACC, FSCCT, FSCMR - Diagnosis, stratification & management - Mapping ⬆️sensitivity & prognosis in ICI-Myocarditis - ⚠️ Challenges: wait times, availability -🚀 Opportunities: Faster tailored protocols & AI tools

Want to learn about #AF management in #CardioOnc? You still can join this amazing #ACC25 session

#ACC2025 #CardioOnc session on starting soon! 🤔- Are we OK with some treatment-related heart failure, hypertension? 🤔- Should we rechallenge some patients post-ICI myocarditis? Join us to learn more about permissive cardiotoxicity! American College of Cardiology JACC Journals

Huge turnout for the #afib and #cardioonc session. Great pearls for managing this common issue in the setting of SCT, amyloid and BTK inhibitors #ACC25 #jacccardioonc

Pre #ACC25 7 mile run! 🏃 #training #broadstreetrun

Experts from around the world discussed various topics related to permissive #cardiotoxicity. Panelist, #JACCCardioOnc EiC Dr. Bonnie Ky noted that a 🔑 takeaway was that pretreatment with steroids is not recommended to prevent ICI #Myocarditis #ACC25 #CardioOnc The Penn Thalheimer Center for Cardio-Oncology

Lenvatinib is associated with increased CV events ✅ most common CV events are hypertension and HF ✅ older age significantly associated with incident CV events #cardioonc #jacccardioonc #acc25

My first JACC:CardioOncology JACC Journals Editorial Board meeting has come to an end! The Penn Thalheimer Center for Cardio-Oncology Great honor to learn from the masters of CardioOncology to discuss future projects 🔬Pedro Moliner Novi Yanti Sari Raul Cordoba, MD, PhD Mike Fradley, MD

Final day at #acc25 and we’ve still got great #cardioonc sessions going on now #jacccardioonc

#ACC25 #CardioOnc Don’t miss these JACC Journals #JACCCO simultaneous publications on ICI myocarditis. ✅ Original research on CV outcomes in ICI-myocarditis tinyurl.com/5n79fh7b ✅ Clinical case on rechallenge post-ICI myocarditis: tinyurl.com/5x7wnhmn

Congratulations to Bonnie Ky, MD, MSCE, FACC on winning the 2025 Distinguished Scientist Award (Translational Domain)! As a leader in #CardioOnc, her work is shaping the future of the field. #ACC25 #JACCCardioOnc @jaccjournals @pennthalheimer youtube.com/watch?v=I_meTO…

🚨 Just one week to go! The 2nd Annual Middle East #CardioOnc Congress lands in Dubai 🌍 on April 26–27, 2025—chaired by Dr. Hadi Skouri 🫀Don’t miss two days of impactful discussions and global networking! 👉 mecocongress.com #CardioOncology #CardioTwitter

Cardiovascular Manifestations From Therapeutic Radiation: A Multidisciplinary Expert Consensus Statement From the International Cardio-Oncology Society spkl.io/6013fa8UX JACC Journals

As a global organization, we're proud to have over 70 #CardioOncology Centers of Excellence around the world. Find one near you: tinyurl.com/4wba9e4t #cardioonc

Thank you for the invitation! Great opportunity to see friends and meet new colleagues from both Penn Cardiology & University of Penn IM Residency Program. Amazing institution & people! The Penn Thalheimer Center for Cardio-Oncology Mike Fradley, MD Brian Drachman Penn Cardiology Fellows